Sympathetic activity is not increased in L-NAME hypertensive rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 1, 2010, Pages

  Dos Santos, Fernanda Machado ^a   Dias, Daniel Penteado Martins ^a   Da Silva, Carlos Alberto Aguiar ^a   Fazan Jr , Rubens ^a   Salgado, Helio Cesar ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Baroreflex; Nitric oxide; Sympathetic activity

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART RATE; HEART RATE VARIABILITY; HEMODYNAMIC PARAMETERS; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; RENAL SYMPATHETIC NERVE ACTIVITY; SYMPATHETIC TONE;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; CONSCIOUSNESS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HEART RATE; HYPERTENSION; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; NOREPINEPHRINE; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 73549108716     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00449.2009     Document Type: Article

References (56)

1. Akserold S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213: 220-222, 1981.
2. Andresen MC, Kuraoka S, Brown AM. Baroreceptor function and changes in strain sensitivity in normotensive and spontaneously hypertensive rats. Circ Res 47: 821-828, 1980.
3. Banting JD, Wiseman SL, Adams MA. Hypertension without cardiac hypertrophy does not induce a cardiac baroreflex deficit. J Hypertens 14: 1209-1214, 1996.
4. Bernatòvá I, Pechánová O, Babál P, Kyselá S, Stvrtina S, Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 282: H942-H948, 2002.
5. Biancardi VC, Bergamaschi CT, Lopes OU, Campos RR. Sympathetic activation in rats with L-NAME-induced hypertension. Braz J Med Biol Res 40: 401-408, 2007.
6. Blanc J, Ponchon P, Laude D, Elghozi JL, Jover B. Blood pressure variability in established L-NAME hypertension in rats. J Hypertens 17: 1527-1534, 1999.
7. Camilletti A, Moretti N, Giacchetti G, Faloia E, Martarelli D, Mantero F, Mazzanti L. Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients. Am J Hypertens 14: 382-386, 2001.
8. Castellano M, Rizzoni D, Beschi M. Relationship between sympathetic nervous system activity, baroreflex and cardiovascular effects after acute nitric oxide synthesis inhibition in humans. J Hypertens 13: 1153-1161, 1995.
9. Chapleau MW, Cunningham JT, Sullivan MJ, Wachtel RE, Abboud FM. Structural versus functional modulation of the arterial baroreflex. Hypertension 26: 341-347, 1995.
10. Cunha RS, Cabral AM, Vasquez EC. Evidence that the autonomic nervous system plays a mayor role in the L-NAME induced hypertension in conscious rats. Am J Hypertens 6: 806-809, 1993.
11. De Angelis Ogawa T, Sanches IC, Rigatto KV, Krieger EM, Irigoyen MC. Impairment on cardiac output and blood flow adjustments exercise in L-NAME-induced hypertensive rats. J Cardiovas Pharmacol 47: 371-376, 2006.
12. DiBona GF, Jones SY. Analysis of renal sympathetic nerve responses to stress. Hypertension 25: 531-538, 1995.
13. Esler M, Lambert G, Jennings G. Increased regional sympathetic nervous activity in human hypertension: causes and consequences. J Hypertens Suppl 8: 53-57, 1990.
14. Esler M. The sympathetic system and hypertension. Am J Hypertens 13: 99-105, 2000.
15. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
16. Granger J, Novak J, Schnackenberg C, Williams S, Reinhart GA. Role of renal nerves in mediating the hypertensive effects of nitric oxide synthesis inhibition. Hypertension 27: 613-618, 1996.
17. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension obesity, and congestive heart failure. Hypertension 31: 64-67, 1998.
18. Guzzetti S, Piccaluga E, Casati R, Cerutti S, Lombardi F, Pagani M, Malliani A. Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens 6: 711-717, 1988.
19. Hirai T, Musch TI, Morgan DA, Kregel KC, Claassen DE, Pickar JG, Lewis SJ, Kenney MJ. Differential sympathetic nerve responses to nitric oxide synthase inhibition in anesthetized rats. Am J Physiol Regul Integr Comp Physiol 269: R807-R813, 1995.
20. Höhler B, Mayer B, Kummer W. Nitric oxide synthase in the rat carotid body and carotid sinus. Cell Tissue Res 276: 559-564, 1994.
21. Julien C, Zhang ZQ, Cerutti C, Barrès C. Hemodynamic analysis of arterial pressure oscillations in conscious rats. J Auton Nerv Syst 50: 239-252, 1995.
22. Kanbar R, Orea V, Barres C, Julien C. Baroreflex control of renal sympathetic nerve activity during air-jet stress in rats. Am J Physiol Regul Integr Comp Physiol 292: R362-R367, 2007.
23. Lantelme P, Lo M, Sassard J. Decreased cardiac baroreflex sensitivity is not due to cardiac hypertrophy in NG-nitro-L-arginine methyl ester-induced hypertension. J Hypertens 12: 791-795, 1994.
24. Li Z, Chapleau MW, Bates JN, Bielefeldt K, Lee HC, Abboud FM. Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons. Neuron 20: 1039-1049, 1998.
25. Liu Y, Tsuchihashi T, Kagiyama S, Matsumura K, Abe I, Fujishima M. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats. J Hypertens 16: 1165-1173, 1998.
26. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84: 482-492, 1991.
27. Marquadt DW. An algorithm for least-squares estimates of non-linear parameters. J Soc Ind Appl Math 11: 431-441, 1967.
28. Matsuda T, Bates JN, Lewis SJ, Abboud FM, Chapleau MW. Modulation of baroreceptor activity by nitric oxide and S-nitrosocysteine. Circ Res 76: 426-433, 1995.
29. Matsuoka H, Nishida H, Nomura G, Van Vliet BN, Toshima H. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 23: 971-975, 1994.
30. Miao CY, Shen FM, Su DF. Blood pressure variability is increased in genetic hypertension and L-NAME induced hypertension. Acta Pharmacol Sin 22: 137-140, 2001.
31. Moss MB, Brunini TM, Soares De Moura R, Novaes Malagris LE, Roberts NB, Ellory JC, Mann GE, Mendes Ribeiro AC. Diminished L-arginine bioavailability in hypertension. Clin Sci 107: 391-397, 2004.
32. Navarro-Cid J, Maeso R, Rodrigo E, Muñoz-Garcý́a R, Ruilope LM, Lahera V, Cachofeiro V. Renal and Vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs. Am J Hypertens 9: 1077-1083, 1996.
33. Nosaka S, Wang SC. Carotid sinus baroceptor functions in the spontaneously hypertensive rat. Am J Physiol 222: 1079-1084, 1972.
34. Pagani M, Somers V, Furlan R, Dell'Orto S, Conway J, Baselli G, Cerutti S, Sleight P, Malliani A. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension 12: 600-610, 1988.
35. Patel KP, Li YF, Hirooka Y. Role of nitric oxide in central sympathetic outflow. Exp Biol Med (Maywood) 226: 814-824, 2001.
36. Persson PB, Baumann JE, Ehmke H, Nafz B, Wittmann U, Kirchheim HR. Phasic and 24-h blood pressure control by endothelium-derived relaxing factor in conscious dogs. Am J Physiol Heart Circ Physiol 262: H1395-H1400, 1992.
37. Ramchandra R, Barrett CJ, Malpas SC. Nitric oxide and sympathetic nerve activity in the control of blood pressure. Clin Exp Pharmacol Physiol 32: 440-446, 2005.
38. Ramchandra R, Barret CJ, Guild SJ, McBryde F, Malpas SC. Role of renal sympathetic nerve activity in hypertension induced by chronic nitric oxide inhibition. Am J Physiol Regul Integr Comp Physiol 292: R1479-R1485, 2007.
39. Reinhart GA, Lohmeier TE, Mizelle HL. Temporal influence of the renal nerves on renal excretory function during chronic inhibition of nitric oxide synthesis. Hypertension 29: 199-204, 1997.
40. Ribeiro MO, Antunes E, De NG, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20: 298-303, 1992.
41. Rimoldi O, Pierini S, Ferrari A, Cerutti S, Pagani M, Malliani A. Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs. Am J Physiol Heart Circ Physiol 258: H967-H976, 1990.
42. Rondon E, Brasileiro-Santos MS, Moreira ED, Rondon MUPB, Mattos KC, Coelho MA, Silva GJJ, Brum PC, Fiorino P, Irigoyen MC, Krieger EM, Middlekauff HR, Negrão CE. Exercise training improves aortic depressor nerve sensitivity in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 291: H2801-H2806, 2006.
43. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ Res 70: 607-611, 1992.
44. Salgado MCO, Justo SVS, Joaquim LF, Fazan R Jr, Salgado HC. Role of nitric oxide and prostanoids in attenuation of rapid baroreceptor resetting. Am J Physiol Heart Circ Physiol 290: H1059-H1063, 2006.
45. ω-nitro-L-arginine methyl ester. Hypertension 30: 64-70, 1997.
46. Scrogin HCD, Hatton DC, Chi Y, Luft FC. Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system. Am J Physiol Regul Integr Comp Physiol 274: R367-R374, 1998.
47. Scrogin KE, Veelken R, Luft FR. Sympathetic baroreceptor responses after chronic NG-nitro-L-arginine methyl ester treatment in conscious rats. Hypertension 23: 982-986, 1994.
48. Silva VJD, Viana PCC, Alves RM, Salgado HC, Montano N, Fazan Jr. R. Antihypertensive action of amiodarone in spontaneously hypertensive rats. Hypertension 38: 597-601, 2001.
49. Souza HC, Ballejo G, Salgado MC, Da S, V, Salgado HC. Cardiac sympathetic overactivity and decreased baroreflex sensitivity in L-NAME hypertensive rats. Am J Physiol Heart Circ Physiol 280: H844-H850, 2001.
50. Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, Kruszelnicka-Kwiatkowska O, Kokot F, Dubiel JS, Froelich JC. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 33: 652-658, 1999.
51. Task Force of the European Society of Cardiology, and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043-1065, 1996.
52. Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, Levi R. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 262: 343-347, 1992.
53. Vasquez EC, Cunha RS, Cabral AM. Baroreceptor reflex function in rats submitted to chronic inhibition of nitric oxide synthesis. Braz J Med Biol Res 27: 767-774, 1994.
54. Wang DS, Xie HH, Shen FM, Cai GJ, Su DF. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats. Clin Exp Pharmacol Physiol 32: 545-552, 2005.
55. Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M. Agerelated changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 13: 870-877, 1989.
56. Zucker IH, Wang W. Reflex control of renal sympathetic nervous activity in heart failure. Herz 16: 82-91, 1991.